Co-Diagnostics, Inc. (CODX)
4.71
-0.17
(-3.48%)
USD |
NASDAQ |
Jun 11, 14:43
Co-Diagnostics Total Assets (Quarterly) : 21.50M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 21.50M |
| December 31, 2025 | 27.12M |
| September 30, 2025 | 44.74M |
| June 30, 2025 | 46.47M |
| March 31, 2025 | 55.15M |
| December 31, 2024 | 70.76M |
| September 30, 2024 | 72.38M |
| June 30, 2024 | 80.70M |
| March 31, 2024 | 86.67M |
| December 31, 2023 | 103.65M |
| September 30, 2023 | 108.68M |
| June 30, 2023 | 112.80M |
| March 31, 2023 | 117.00M |
| December 31, 2022 | 128.23M |
| September 30, 2022 | 147.84M |
| June 30, 2022 | 160.84M |
| March 31, 2022 | 171.15M |
| December 31, 2021 | 160.59M |
| September 30, 2021 | 105.36M |
| June 30, 2021 | 92.79M |
| March 31, 2021 | 81.12M |
| Date | Value |
|---|---|
| December 31, 2020 | 71.24M |
| September 30, 2020 | 54.65M |
| June 30, 2020 | 38.79M |
| March 31, 2020 | 20.48M |
| December 31, 2019 | 2.215M |
| September 30, 2019 | 3.812M |
| June 30, 2019 | 5.318M |
| March 31, 2019 | 6.121M |
| December 31, 2018 | 1.553M |
| September 30, 2018 | 2.713M |
| June 30, 2018 | 1.969M |
| March 31, 2018 | 3.327M |
| December 31, 2017 | 4.662M |
| September 30, 2017 | 6.052M |
| June 30, 2017 | 0.4676M |
| March 31, 2017 | 0.7865M |
| December 31, 2016 | 1.296M |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | 0.3709M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Fractyl Health, Inc. | 99.38M |
| Spectral AI, Inc. | 17.73M |
| Sangamo Therapeutics, Inc. | 59.96M |
| INmune Bio, Inc. | 25.82M |
| Arrowhead Pharmaceuticals, Inc. | 2.268B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 5.457M |
| Shareholders Equity (Quarterly) | 16.04M |
| Debt to Equity Ratio | 0.1266 |
| Current Ratio | 2.283 |
| Net Debt Paydown Yield | 0.36% |